4710 Filanesib (ARRY-520) Demonstrates Potent and Rapid Activity in Preclinical Models of MM, Dependent on Bcl-2 Family Expression, and Synergistic with Dexamethasone and IMiDs
TAKE THAT O THE BANK look for a nice pop
I believe you are pretty accurate with the 30.00 est in 18 months.............. I might add IF ARRY doesn't get bought out before that. HUGE late stage pipeline
report from yesterday , straight from ARRYs PR
" The European Commission is expected to issue a decision regarding the Novartis-GSK transaction on January 28, 2015."
IMO this is just the start of many good things coming our way for 2015/2016
Earnings Feb 3 2015
ARRY still showing heavy accumulation last few days, nice manipulation going on to keep a lid on the pps. again once the big boys are finished accumulating they will let it run. Look at the SEC filing Black Rock now owns 8.5% according to the 13g filed a week ago or 2. Most their shares were bought in the 5 range and upper 4's
Too many positive and now more than ever a top rated buyout candidate, with its current pipeline look for offer to hit the table once the NVS/GSK deal closes first 1/2 of 2015
Take a hard look at ARRY the next JAZZ target 15.00 HUGE pipeline and 93% institutional ownership sitting on 142 million cash and will receive another 85 million within 4 months. Research it
"CURRENT" fair value is right about $16.00 - $18.00 dollars with current pipeline and cash at hand......plus another $ 85 million within the first 1/2 of 2015
BIG money will go at all cost to keep a lid on the PPS while they finish accumulating , ARRY is a "GOLDMINE" with a HUGE potential . Buy now and come back in EOY. I see ARRY in the 25-30 .00 dollar range, that's if they get bought out first.